Navigation Links
Researcher finds way to identify aggressive cancers in black women
Date:12/11/2013

African-American women who get breast cancer often get more aggressive forms of the disease and at younger ages than other women.

But a Georgia State University researcher has found a way to identify these aggressive cancers in black women, which would let their doctors customize their treatment.

Ritu Aneja, associate professor of biology, has been studying a protein called HSET. Earlier studies have linked elevated levels of HSET to the spread of lung cancer to the brain. Others have found that HSET is also abnormally high in a particularly vicious kind of breast cancer, called triple-negative breast cancer, that most commonly occurs in African-American women.

Aneja's federally funded work went a step beyond to see if tests for the protein could help doctors identify aggressive breast cancers in African-American patients. She and her colleagues analyzed breast tumor tissue samples from 149 African-American women and 44 non-Hispanic white women.

She found the samples from African-American women were three times as likely to show high levels of HSET. Her team was also able to link elevated HSET levels to poorer medical outcomes for African American women, but not in white women.

"We were surprised that HSET levels appeared to be a better predictor of cancer outcomes than other routinely used breast cancer predictors," Aneja said. "We are working round the clock to define ways to use this biomarker most effectively and as soon as possible in a clinical setting."

The research was presented at the sixth American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, which took place Dec. 6-9.


'/>"/>

Contact: Ann Claycombe
claycombe@gsu.edu
404-413-5047
Georgia State University
Source:Eurekalert  

Page: 1

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
3. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
4. U of Alberta researcher steps closer to understand autoimmune diseases
5. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
6. UNH researchers find African farmers need better climate change data to improve farming practices
7. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
8. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
9. Researchers print live cells with a standard inkjet printer
10. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
11. Researchers reveal how a single gene mutation leads to uncontrolled obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researcher finds way to identify aggressive cancers in black women
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... of the "Global Wearable Technologies Market and ... Overview, Trends and Forecast 2014-2020" report to ... are smart devices that can be worn on ...
(Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ) ... Global Watermarking and Fingerprinting Markets" report to ... This insight provides an overview ... markets. Watermarking aims to control and monitor piracy ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2
... Crop Science Society of America (CSSA) announces the following 2012 ... Oct. 21-24, 2012 in Cincinnati, OH. Members of the Society ... service. Only 0.3 percent of the Society,s active and emeritus ... Fellows are: Marc C. Albertsen, Dupont Pioneer - ...
... must account for the complexity of the human impact ... and temporal scales. "Scale-sensitive research" emerges as a new, ... analyses, and tools to the scale in which these ... that the decisions they take resolve ecological problems at ...
... - When Washington State University and U.S. Department of Agriculture ... a rare but deadly infection was discovered among a group ... adrenaline. Not only were the horses infected with a parasitic ... the outbreak was at no ordinary ranch. It ...
Cached Biology News:Crop Science Society of America presents 2012 class of fellows 2Crop Science Society of America presents 2012 class of fellows 3Scientists call policy-makers to be scale-aware 2Scientists call policy-makers to be scale-aware 3WSU/USDA scientist creates test, treatment for malaria-like sickness in horses 2WSU/USDA scientist creates test, treatment for malaria-like sickness in horses 3WSU/USDA scientist creates test, treatment for malaria-like sickness in horses 4
(Date:1/22/2015)... 22, 2015 Eckert & Ziegler Vitalea ... (AMS) services to the pharmaceutical and biotech industry, has ... company in the position of Director of Science & ... and valuable experience in drug metabolism and bioanalysis to ...
(Date:1/22/2015)... RBJ today announces the firm brokered a long-term lease totaling ... biopharmaceutical company, at Two Ledgemont Center in Lexington, ... president, and Brian Cohen , senior vice president, represented ... 95 Hayden Ave. Photo - http://photos.prnewswire.com/prnh/20150122/170765 ...
(Date:1/22/2015)... 2015 Crystal Diagnostics (CDx) Xpress System, a ... received AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing E. ... referred to as STEC or the “Big-6”) as well as ... (cfu) per 325 g of raw ground beef and raw ...
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project ... the legal requirements around using controlled substances in pharmaceutical ... As their international operations expand and become increasingly complex, ... as a result of the first phase of the ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Global Compliance Service for Controlled Substances to Expand to China 2
... at the Diabetes... -- JERUSALEM, November 15, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
... Kienberger received the 2010 ICO Prize for pioneering contributions ... this new scientific discipline is to capture snapshots of ... to yield important insights into the actual course of ... and the interactions between light and matter. "An ...
... CAMBRIDGE, Massachusetts, November 12, 2010 ... ... lpUnit=,PRN,; --> ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
Cached Biology Technology:Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 2Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 3Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 4Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 5Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 6Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 7Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 8Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 92010 ICO Prize is awarded to TUM physicist Reinhard Kienberger 2Cell Press Delivers the News 2Cell Press Delivers the News 3Cell Press Delivers the News 4Cell Press Delivers the News 5Cell Press Delivers the News 6Cell Press Delivers the News 7
... low background ,This solution greatly enhances antigen-antibody ... than obtained with conventional methods. ,Two kinds ... secondary antibodies, which can suppress the background ... Wide versatility ,It is applicable to various ...
Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3 Monoclonal Antibody Family: Immunoglobulin Sub-Family: not assigned-Immunogl...
pH-dependent fluorescence; Maximum intensity observed in basic solutions....
Mouse anti human pro-Relaxin-2...
Biology Products: